Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production

• Published in: Cell metabolism 2015-09, Vol.22 (3), p.460-471
• Main Authors: Metghalchi, Sarvenaz, Ponnuswamy, Padmapriya, Simon, Tabassome, Haddad, Yacine, Laurans, Ludivine, Clément, Marc, Dalloz, Marion, Romain, Mélissa, Esposito, Bruno, Koropoulis, Vincent, Lamas, Bruno, Paul, Jean-Louis, Cottin, Yves, Kotti, Salma, Bruneval, Patrick, Callebert, Jacques, den Ruijter, Hester, Launay, Jean-Marie, Danchin, Nicolas, Sokol, Harry, Tedgui, Alain, Taleb, Soraya, Mallat, Ziad
• Format: Article
• Language: English
• Subjects: Animals; Atherosclerosis - genetics; Atherosclerosis - immunology; Atherosclerosis - pathology; Biochemistry, Molecular Biology; Colitis - genetics; Colitis - immunology; Colitis - pathology; Female; Gene Deletion; Humans; Immunity; Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics; Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology; Interleukin-10 - genetics; Interleukin-10 - immunology; Kynurenic Acid - immunology; Life Sciences; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Myocardial Infarction - genetics; Myocardial Infarction - immunology; Myocardial Infarction - pathology
• ISSN: 1550-4131; 1932-7420
• DOI: 10.1016/j.cmet.2015.07.004

Indoleamine 2,3-dioxygenase 1 (Ido1) is a rate-limiting enzyme that catalizes the degradation of tryptophan along the kynurenine pathway. Here, we show that Ido1 activity sustains an immunostimulatory potential through inhibition of interleukin (Il)10. In atherosclerosis, Ido1-dependent inhibition of Il10 translates into disease exacerbation. The resistance of Ido1-deficient mice to enhanced immune activation is broken in Ido1/Il10 double-deficient mice, which show exaggerated immune responses and develop severe spontaneous colitis. We demonstrate that Ido1 activity is required for the regulation of Il10 and that kynurenic acid (Kna), an Ido1-derived metabolite, is responsible for reduced Il10 production through activation of a cAMP-dependent pathway and inhibition of Erk1/2 phosphorylation. Resupplementation of Ido1-deficient mice with Kna limits Il10 expression and promotes atherosclerosis. In human atherosclerotic lesions, increased levels of Kna are associated with an unstable plaque phenotype, and its blood levels predict death and recurrent myocardial infarction in patients with coronary artery disease. [Display omitted] •Absence of Ido1 protects against atherosclerosis through increase of Il10•Ido-derived metabolite Kna inhibits Il10 through increase of intracellular cAMP•High levels of Kna is of bad prognosis in patients with cardiovascular diseases•Double deficiency Ido1/Il10 leads to spontaneous severe colitis Metghalchi et al. show that Ido1 activity sustains an immunostimulatory potential through inhibition of Il10. In atherosclerosis, Ido1-dependent inhibition of Il10 translates into disease exacerbation. The resistance of Ido1-deficient mice to enhanced immune activation is broken in Ido1/Il10 double-deficient mice, which show exaggerated immune responses and develop severe spontaneous colitis.